TERIPARATIDE USE IN THE TREATMENT OF SEVERE HYPOCALCEMIA AFTER KIDNEY TRANSPLANTATION: A CASE REPORT

This case report details the successful treatment of severe, recalcitrant hypocalcemia in a kidney transplant recipient using teriparatide. A 30-year-old woman, who had undergone parathyroidectomy nine years prior, developed hypocalcemia post-transplant. Despite increased oral and intravenous calcium and vitamin D, her calcium levels remained low. Teriparatide was administered, resulting in a rapid normalization of calcium levels and allowing for cessation of intravenous calcium and reduced oral supplementation. The authors conclude that teriparatide is a safe and effective treatment option for refractory hypocalcemia after kidney transplantation, particularly in patients with prior parathyroidectomy, potentially reducing hospital stay and medication burden.

SHMohammad Ismail, D Simatherai, BCBee, HSWong, Yakob